PKTX 8-K (Dupuy resignation)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of
Report: September 16, 2005
PROTOKINETIX,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
________________________________
|
000-32917
___________________________
|
94-3355026
______________________________
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
Commission
File Number
|
(IRS
Employer
Identification
Number)
|
Suite
1500-885 West Georgia Street
Vancouver,
British Columbia Canada V6C 3E8
(Address
of principal executive offices)
________________________________________________
Dr.
John
Todd
President
Suite
1500-885 West Georgia Street
Vancouver,
British Columbia Canada V6C 3E8
(Name
and
address of agent for service)
(604)
687-9887
(Telephone
number, including area code of agent for service)
with
a
copy to:
Mark
L.
Baum, Esq.
The
Baum
Law Firm
580
2nd
Street, Suite 102
Encinitas,
CA 92024
(760)
230-2300
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d- 2(b))
[
] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e- 4(c))
ITEM
5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
Effective
September 16, 2005, Dr. J.M. Dupuy resigned from the Company's Board of
Directors. There was not a dispute or controversy related to Dr. DuPuy's
departure from the ProtoKinetix Board of Directors.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date:
November 2, 2005
PROTOKINETIX,
INC.
By:
/s/
Dr. John Todd
Dr.
John
Todd
President
and CEO